Ginkgo completes sale of Biosecurity segment to Tower Biosecurity, retains 20% stake

Ginkgo Bioworks Holdings, Inc.

On April 3, 2026, Ginkgo contributed all Biosecurity equity to Tower Biosecurity (Perimeter Systems) for ~20% of buyer's fully diluted shares.
Biosecurity will be reported as discontinued operations starting Q1 2026; pro forma results show reduced operating losses.
Pro forma 2025 net loss improved to $287.8M from $312.8M; 2024 loss improved to $507.6M from $547.0M.
The retained 20% stake will be equity-method accounted; preliminary valuation of $12.3M.
Ginkgo and Tower entered a Transition Services Agreement for temporary services.

item 2.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.